Suppr超能文献

欧洲乳糜泻与非霍奇金淋巴瘤多中心研究。

European multi-centre study on coeliac disease and non-Hodgkin lymphoma.

作者信息

Mearin M Luisa, Catassi Carlo, Brousse Nicole, Brand Ronald, Collin Pekka, Fabiani Elisabetta, Schweizer Joachim J, Abuzakouk Mohamed, Szajewska Hania, Hallert Claes, Farré Masip Carme, Holmes Geoffrey K T

机构信息

Department of Paediatrics, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Eur J Gastroenterol Hepatol. 2006 Feb;18(2):187-94. doi: 10.1097/00042737-200602000-00012.

Abstract

INTRODUCTION

Coeliac disease (CD) is associated with an increased risk of non-Hodgkin lymphoma (NHL), but there is little information about whether this is true for clinically silent CD.

OBJECTIVE

To investigate the frequency of CD in two European populations; one with NHL and another derived from the general population.

METHODS

A prospective, multi-centre, case-control study in 10 European countries was conducted between May 1998 and April 2001. A total of 1446 consecutive patients with newly diagnosed NHL aged over 18 years was collected. The control group consisted of a population of 9676 individuals who were screened for CD. The number of patients with a previous diagnosis of CD and those with silent CD detected by screening were determined in the two groups.

RESULTS

The patients with CD had a significantly increased risk of developing NHL [odds ratio (OR) 2.6, 95% confidence interval (CI) 1.4-4.9]. This risk was only present in patients with CD diagnosed clinically before the study (OR 3.3, 95% CI 1.4-7.9), but not in those with silent CD detected by screening (OR 1.3, 95% CI 0.6-2.7).

CONCLUSION

Patients with CD have an increased risk of developing NHL, although this is lower than previously thought. Clinically silent CD is rare in patients with NHL.

摘要

引言

乳糜泻(CD)与非霍奇金淋巴瘤(NHL)风险增加相关,但对于临床无症状的CD是否如此,相关信息甚少。

目的

调查两个欧洲人群中CD的发生率;一组为NHL患者,另一组来自普通人群。

方法

1998年5月至2001年4月在10个欧洲国家开展了一项前瞻性、多中心病例对照研究。共收集了1446例年龄超过18岁、新诊断为NHL的连续患者。对照组由9676名接受CD筛查的个体组成。确定两组中既往诊断为CD的患者数量以及筛查发现的无症状CD患者数量。

结果

CD患者发生NHL的风险显著增加[比值比(OR)2.6,95%置信区间(CI)1.4 - 4.9]。这种风险仅存在于研究前临床诊断为CD的患者中(OR 3.3,95% CI 1.4 - 7.9),而筛查发现的无症状CD患者中不存在(OR 1.3,95% CI 0.6 - 2.7)。

结论

CD患者发生NHL的风险增加,尽管低于先前的认知。临床上无症状的CD在NHL患者中罕见。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验